Physician profile
Christopher Paul
NPI 1487940656
$63,649.03
in general payments reported to CMS, 2019-2025
24 companies · $30K in 2025
The $30K reported for 2025 was more than what 98% of Pain Medicine (Anesthesiology) providers received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,103 · 2020: $940 · 2021: $462 · 2022: $640 · 2023: $4,692 · 2024: $24K · 2025: $30K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $18K · Consulting Fee: $18K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $10K · Food and Beverage: $7,655 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $4,500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $18,230.36 |
| Consulting Fee | $18,094.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $10,025.00 |
| Food and Beverage | $7,654.85 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $4,500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mml US, INC. | $41,186.30 | 2023-2025 | Reactiv8 |
| Abbott Laboratories | $13,890.12 | 2019-2025 | Proclaim, Ionicrf |
| Saluda Medical Americas, INC. | $4,236.06 | 2022-2024 | Evoke Scs, Evoke |
| Stryker Corporation | $952.72 | 2019-2025 | Mild Device Kit |
| Nevro Corp. | $813.77 | 2019-2024 | Senza |
| Boston Scientific Corporation | $467.67 | 2019-2025 | Intracept, Wavewriter Alpha Prime 16, General - Pain Management |
| Spr Therapeutics, INC | $422.49 | 2019-2025 | Sprint Pns System |
| Medtronic USA, INC. | $415.13 | 2020 | |
| Relievant Medsystems, INC. | $341.58 | 2019-2023 | Intracept |
| Globus Medical, INC. | $182.88 | 2025 | Senza |
| Stratus Medical, LLC | $111.29 | 2020-2023 | Nimbus |
| Novo Nordisk INC | $98.89 | 2023-2024 | Wegovy |
| Medtronic, INC. | $95.21 | 2021-2023 | Kyphon Express II Kyphopak Tray, Intellis Adaptivestim |
| Si-Bone, INC. | $89.00 | 2019 | |
| Lilly USA, LLC | $69.18 | 2024-2025 | Zepbound, Emgality, Jardiance |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Averitas Pharma INC. | $66.46 | 2024-2025 | Qutenza |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $44.39 | 2020-2025 | Relistor |
| Scilex Pharmaceuticals INC. | $36.43 | 2020 | |
| Collegium Pharmaceutical, INC. | $31.28 | 2020-2021 | |
| Nalu Medical, INC. | $24.91 | 2023 | Nalu Neurostimulation System |
| Edwards Lifesciences Corporation | $22.85 | 2019 | |
| Spinal Simplicity, LLC | $19.58 | 2025 | Ha Minuteman G3-R |
| Avanos Medical | $16.19 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $14.65 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Paul listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.